Profiling the ‘immune landscape’ of patient’s tumours reveals who will most benefit from radiotherapy with potential immunotherapy in bowel cancer. Tumours which are chronically Inflamed before treatment could be made more susceptible using targeted immunotherapies

Scientists have used artificial intelligence to reveal an aggressive form of pancreatic cancer that is more likely to respond to immunotherapy, in the most extensive analysis of the immune landscape of these tumours to date.

Imperial College London researchers are trialling cannabis-based medicinal products for the treatment of cancer and acute pain. The researchers are collaborating with medical cannabis company EMMAC Life Sciences and The Institute of Cancer Research, London, to better understand the effectiveness of the products.